Using the acquired GNAS hotspot mutation as the prototypic IPMN change, Matthaei et al. studied precursors that were between 2 mm and 7 mm and noted GNAS mutations, favoring emerging IPMNs [66]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.